ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.16
-0.24 (-1.07%)
At close: Mar 6, 2026, 4:00 PM EST
22.33
+0.17 (0.77%)
After-hours: Mar 6, 2026, 6:19 PM EST
ACADIA Pharmaceuticals Employees
As of December 31, 2025, ACADIA Pharmaceuticals had 798 total employees, including 796 full-time and 2 part-time employees. The number of employees increased by 144 or 22.02% compared to the previous year.
Employees
798
Change (1Y)
144
Growth (1Y)
22.02%
Revenue / Employee
$1,342,738
Profits / Employee
$489,975
Market Cap
3.78B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,609 |
| Corcept Therapeutics | 730 |
| ADMA Biologics | 685 |
| Crinetics Pharmaceuticals | 594 |
| Xenon Pharmaceuticals | 370 |
| Alumis | 223 |
| Structure Therapeutics | 220 |
| Centessa Pharmaceuticals | 114 |
ACAD News
- 4 days ago - Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors - Business Wire
- 5 days ago - Acadia Pharmaceuticals Announces Plan to Request Re-Examination Following Negative CHMP Opinion for Trofinetide for the Treatment of Rett Syndrome - Business Wire
- 7 days ago - Acadia Pharmaceuticals: Undervalued Despite Robust Revenues From Approved Drugs, With Pipeline Kicker - Seeking Alpha
- 9 days ago - ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operating Overview - Business Wire
- 12 days ago - Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - Business Wire
- 4 weeks ago - Alger Weatherbie Specialized Growth Fund Q4 2025 Winners And Laggards - Seeking Alpha